Login

Financial Snapshot

Revenue
TTM
$96.36B
Gross Margin
TTM
67.92%
Net Income
TTM
$21.04B
Current Assets
2026 Q1
Current Liabilities
2026 Q1
Current Ratio
2026 Q1
102.52%
Total Assets
2026 Q1
Total Liabilities
2026 Q1
Book Value
2026 Q1
$81.19B
Cash
2026 Q1
P/E
TTM
25.50
Free Cash Flow
TTM
$17.78B

Stock Price

Loading...
Market Cap: $536.55 Billion

About Johnson & Johnson

Johnson & Johnson (NYSE: JNJ) is a pharmaceutical and medical device company headquartered in New Brunswick, New Jersey. The filing excerpts from the 10-K filed February 11, 2026 (accession 000020040626000016) confirm J&J's registration under the Securities Exchange Act and its principal offices at One Johnson & Johnson Plaza, New Brunswick, New Jersey 08933. The excerpts do not provide sufficient detail on segment revenue, product lines, geographic mix, leadership, or competitive position to support additional factual claims in this description. Further filing sections are required to complete a fully grounded business summary.

Source: SEC 10-K, filed 2026-02-11

Industry: Pharmaceutical Preparations Peers: Bristol-Myers Squibb Co Catalent, Inc. Eli Lilly and Co Merck & Co Inc Organon & Co Pfizer Inc Royalty Pharma PLC Viatris Inc Zoetis Inc

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support